These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4568899)

  • 1. [Effect of E.coli-L-asparaginase alone or in combination with INH or PAS on the course of experimental tuberculosis in guinea pigs].
    Schwartz E; Badalík L
    Bratisl Lek Listy; 1972 Dec; 58(6):697-707. PubMed ID: 4568899
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoniazide-tiocarlide combination or DAT in the treatment of pulmonary tuberculosis. Comparison with isoniazide-PAS combination and especially BPAS].
    Meyer A; Nadjar-Fossé G
    Rev Tuberc Pneumol (Paris); 1968; 32(3):371-80. PubMed ID: 5693998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1975 Jul; 50(7):191-7. PubMed ID: 810615
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies with isoniazid alone, isoniazid with thiacetazone and isoniazid with para-aminosalicylic acid in ambulatory treatment of pulmonary tuberculosis.
    Patel RB; Patel TL; Mehta HC
    J Indian Med Assoc; 1967 May; 48(10):471-8. PubMed ID: 4167188
    [No Abstract]   [Full Text] [Related]  

  • 14. Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early and late results of massive antitubercular chemotherapy in previously untreated pulmonary tuberculosis in adults].
    Sosnowski W; Kubiak Z
    Gruzlica; 1972 Jan; 40(1):21-8. PubMed ID: 5011722
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug resistance among previously treated tuberculosis patients, a brief report.
    Costello HD; Caras GJ; Snider DE
    Am Rev Respir Dis; 1980 Feb; 121(2):313-6. PubMed ID: 6767427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemoblastic reaction in a patient with pulmonary tuberculosis developed after the use of tubazid and PAS].
    Samillo GK; Al'tshuler ML
    Vrach Delo; 1974 Sep; 0(9):77-8. PubMed ID: 4428720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.